Asia Resource Centre

Asia Focus: Top 5 Challenges around Pharmacovigilance

Rate this Article: (4.3 Stars | 19 Votes)

There are several challenges around pharmacovigilance in Asia and perspectives are different for Industry, regulatory authorities, academia and healthcare professionals. Dr Deepa Arora MD, Global Head, Drug Safety & Risk Management at Lupin Limited, tells Pharma IQ what she considers to be the Top 5 most common challenges around pharmacovigilance in Asia. Challenge 1 : Poor availability of...
To continue viewing this content please fill out the form below and become an IQ member.
Already an IQ member? Sign in

First Name*
Last Name*
E-mail*
Phone*
Job Title*
Company*
Country
State
Username*
Password*
Confirm Password*

About Asia Resource Centre


Providing up-to-date content that offers both relevant information and knowledge on Asia in the pharmaceutical space,  is the main driver behind the Asia Focus Centre. Asia is the world's largest and most populated continenant and is at the epicentre of most pharmaceutical companies' strategies.

Deepa Arora Contributor: Deepa Arora



comments powered by Disqus

Advertise With Us

Join the Pharmas IQ Community